Helicobacter pylori as a class I carcinogen: Physiopathology and management strategies
- 7 May 2007
- journal article
- review article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 102 (2), 264-273
- https://doi.org/10.1002/jcb.21375
Abstract
The gram‐negative bacterium Helicobacter pylori is known as a persistent colonizer of the human stomach, and probably less known is that it is also involved in extraintestinal diseases. Public awareness of its contribution in the development of gastric cancer is less than 15 years old. The efficacy of the current therapies based on antibiotics against H. pylori has been limited by difficulties such as antibiotic resistance and recurrence. As a consequence, the development of promising vaccines was prompted as the best preventive measure. Unfortunately, so far vaccines failed the transition from animal models to human trials. This keynote presentation is to provide a bird's eye view of H. pylori‐related gastric diseases, including gastric cancer, with a synthesis of the molecular mechanisms involved, and an exhaustive presentation and discussion of the current therapeutic guidelines and future strategies for prevention or therapy. J. Cell. Biochem. 102: 264–273, 2007.Keywords
This publication has 50 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesisJournal of Cellular Physiology, 2007
- Bacterial DNA microarrays for clinical microbiology: the early logarithmic phaseFrontiers in Bioscience-Landmark, 2007
- Napoleon Bonaparte's gastric cancer: a clinicopathologic approach to staging, pathogenesis, and etiologyNature Clinical Practice Gastroenterology & Hepatology, 2007
- Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivoGut, 2006
- Helicobacter pyloriPersistence: an Overview of Interactions betweenH. pyloriand Host Immune DefensesClinical Microbiology Reviews, 2006
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006
- Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycleCellular Microbiology, 2006
- Post‐genomic vaccine developmentFEBS Letters, 2006
- Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infectionThe Lancet, 1996